Tuesday, 22 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14455
Articles
Company
Eurofins DiscoverX Opens Shanghai Office to Expand Asia-Pacific Operations
March 3, 2025
Company
Deals
Solasia Pharma Reduces China Operations, Transfers Drug Rights to Lee’s
March 3, 2025
Policy / Regulatory
NMPA Releases Plans to Support HK and Macau Drug, Device Production in Mainland Cities
March 3, 2025
Company
Drug
Bio-Thera Solutions’ BAT8010 Receives NMPA Approval for Solid Tumor Clinical Trials
March 3, 2025
Company
Drug
Kelun Pharma’s SKB264 ADC Receives Breakthrough Therapy Designation for TNBC
March 3, 2025
Company
R&D
Burning Rock Biotech Launches PREVENT Study for Early Cancer Detection
March 3, 2025
Company
Deals
Harbour BioMed’s Partner NK Celltech Raises RMB 100M in Series A Financing
March 3, 2025
Policy / Regulatory
NMPA Releases 55th Batch of Reference Drugs for Generic Evaluation
March 3, 2025
Company
Drug
BeiGene’s Tislelizumab Shows Survival Benefit in Esophageal Cancer Study
March 3, 2025
Policy / Regulatory
NMPA Releases Work Plans for Temporary Import of Urgently Needed Drugs
March 3, 2025
Company
Drug
Huadong Medicine’s Biosimilar Ozempic (Semaglutide) Wins NMPA Clinical Trial Approval
March 3, 2025
Drug
Jixing Pharmaceuticals Enrolls First Patient in Etripamil Phase III Study for PSVT
March 3, 2025
1
2
…
1,187
1,188
1,189
1,190
1,191
…
1,204
1,205
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?